MAP kinase activation by interleukin-9 in lymphoid and mast cell lines

被引:28
作者
Demoulin, JB
Louahed, J
Dumoutier, L
Stevens, M
Renauld, JC
机构
[1] Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Expt Med Univ, B-1200 Brussels, Belgium
关键词
cytokines; ERK; proliferation;
D O I
10.1038/sj.onc.1206253
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-9 (IL-9) stimulates the proliferation of mast cells and lymphocytes. In the present study, we showed that IL-9 induced a transient phosphorylation of MEK, ERK2 and p90/RSK in murine lymphoid and mast cell lines. ERK2 in vitro kinase activity was also increased upon IL-9 stimulation. Similar results were obtained with IL-4, which had not been previously reported to activate these kinases in hematopoietic cells. Analysis of IL-9 receptor mutants showed that activation of the pathway was correlated with proliferation and with phosphorylation of the adaptor protein SHC, but not IRS2 or GAB2. The MEK inhibitor PD98059 reduced the mitogenic response to IL-4 and IL-9. In addition, expression of a dominant-negative RAS variant blocked ERK phosphorylation and significantly decreased Ba/F3 cell growth in the presence of IL-9, but did not affect expression of pim-1, a STAT target gene. In summary, these results indicate that IL-9 can transiently activate the mitogen-activated protein kinase pathway, which contributes to growth stimulation of hematopoietic cell tines.
引用
收藏
页码:1763 / 1770
页数:8
相关论文
共 43 条
[1]   Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages [J].
Crowley, MT ;
Harmer, SL ;
DeFranco, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1145-1152
[2]   Role of insulin receptor substrate-2 in interleukin-9-dependent proliferation [J].
Demoulin, JB ;
Grasso, L ;
Atkins, JM ;
Stevens, M ;
Louahed, J ;
Levitt, RC ;
Nicolaides, NC ;
Renauld, JC .
FEBS LETTERS, 2000, 482 (03) :200-204
[3]   Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9 [J].
Demoulin, JB ;
Van Roost, E ;
Stevens, M ;
Groner, B ;
Renauld, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25855-25861
[4]  
Demoulin JB, 1998, CYTOKINES CELL MOL T, V4, P243
[5]  
Demoulin JB, 2000, CANCER RES, V60, P3971
[6]  
Demoulin JB, 1996, MOL CELL BIOL, V16, P4710
[7]  
Demoulin JB, 2001, CELL GROWTH DIFFER, V12, P169
[8]   Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras [J].
deRooij, J ;
Bos, JL .
ONCOGENE, 1997, 14 (05) :623-625
[9]   P21RAS ACTIVATION VIA HEMOPOIETIN RECEPTORS AND C-KIT REQUIRES TYROSINE KINASE-ACTIVITY BUT NOT TYROSINE PHOSPHORYLATION OF P21RAS GTPASE-ACTIVATING PROTEIN [J].
DURONIO, V ;
WELHAM, MJ ;
ABRAHAM, S ;
DRYDEN, P ;
SCHRADER, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1587-1591
[10]   Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction [J].
Frödin, M ;
Gammeltoft, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 151 (1-2) :65-77